Fulgent Genetics Inc (FLGT) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Fulgent Genetics Inc   (NASDAQ: FLGT)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Fulgent Genetics Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FLGT Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q1 MRQ) 30.49 % 42.76 % 65.43 % 46.06 %
Gross Margin (Q1 TTM) 38.88 % 43.26 % 66.39 % 46.3 %
Gross Profit Margin 5 Yr. Avg. 50.46 % 44.06 % 64.67 % 47.07 %
EBITDA Margin (Q1 MRQ) -28.34 % 13.35 % 19.59 % 20.57 %
EBITDA Margin (Q1 TTM) -18.83 % 14.81 % 20.86 % 19.07 %
EBITDA Margin 5 Yr. Avg. 4.16 % 15.1 % 31.16 % 22.06 %
Operating Margin (Q1 MRQ) -49.12 % 8.21 % 16.57 % 16.03 %
Operating Margin (Q1 TTM) -33.2 % 8.63 % 17.92 % 16.33 %
Operating Margin 5 Yr. Avg. --5.05 % 8.63 % 14.41 % 17.09 %
Pre-Tax Profit Margin (Q1 MRQ) -36.85 % 6.41 % 10.93 % 13.94 %
Pre-Tax Profit Margin (Q1 TTM) -26.42 % 7.53 % 12.86 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 7.36 % 10.45 % 12.49 %
Net Margin (Q1 MRQ) -35.85 % 5.07 % 8.14 % 11.41 %
Net Margin (Q1 TTM) -23.51 % 5.6 % 9.99 % 10.76 %
Net Margin 5 Yr. Avg. - 5.18 % 6.23 % 9.95 %



Business Segment Profit Margin
 
Accounting Standards Update 2014-09
  Explore Accounting Standards Update 2014-09 Segment  -
Accounting Standards Update 2014-09 Clinical Institutional Contracts
  Explore Accounting Standards Update 2014-09 Clinical Institutional Contracts Segment  -
Accounting Standards Update 2014-09 Clinical Insurance Contracts
  Explore Accounting Standards Update 2014-09 Clinical Insurance Contracts Segment  -
Accounting Standards Update 2014-09 Clinical Patients Contracts
  Explore Accounting Standards Update 2014-09 Clinical Patients Contracts Segment  -
Laboratory Services
  Explore Laboratory Services Segment  -
Laboratory Services Precision Diagnostics
  Explore Laboratory Services Precision Diagnostics Segment  -
Laboratory Services Anatomic Pathology
  Explore Laboratory Services Anatomic Pathology Segment  -
Laboratory Services BioPharma Services
  Explore Laboratory Services BioPharma Services Segment  -
Precision Diagnostics Laboratory Services
  Explore Precision Diagnostics Laboratory Services Segment  -
Anatomic Pathology Laboratory Services
  Explore Anatomic Pathology Laboratory Services Segment  -
BioPharma Services Laboratory Services
  Explore BioPharma Services Laboratory Services Segment  -
United States
  Explore United States Segment  -
China
  Explore China Segment  -
Other countries
  Explore Other countries Segment  -
Foreign
  Explore Foreign Segment  -
Therapeutic Development
  Explore Therapeutic Development Segment  -
Therapeutic Development BioPharma Services
  Explore Therapeutic Development BioPharma Services Segment  -
BioPharma Services Therapeutic Development
  Explore BioPharma Services Therapeutic Development Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q1 MRQ) 2.69 % 14.01 % 0.21 % 1.39 %
Free Cash Flow Margin (Q1 TTM) -35.47 % 9.19 % 13.98 % 9.19 %
Free Cash Flow Margin 5 Yr. Avg. - 10.67 % 15.38 % 14.52 %
Net Cash Flow Margin (Q1 MRQ) -38.01 % 9.5 % -0.02 % 0.13 %
Net Cash Flow Margin (Q1 TTM) -13.76 % 3.4 % 0.08 % 1.81 %
Net Cash Flow Margin 5 Yr. Avg. - 1.3 % 3.13 % 5.85 %
Effective Tax Rate (Q1 MRQ) - 21.66 % 25.41 % 18.83 %
Effective Tax Rate (Q1 TTM) 11 % 26.67 % 22.81 % 19.33 %
Effective Tax Rate 5 Yr. Avg. - 35.11 % 20.39 % 19.86 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.